Who are Silver Sulfadiazine Gauze Dressing Group's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Fetroja, Xenleta, Nuzyra, Nuzyra, Baxdela, Dalvance.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/silver-sulfadiazine-gauze-dressing-group.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Silver Sulfadiazine Gauze Dressing Group — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Silver Sulfadiazine Gauze Dressing Group (Silver Sulfadiazine Gauze Dressing Group) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antibacterial. Area: Wound care.

phase 3 Antibacterial Wound care Small molecule Live · refreshed every 30 min

Target snapshot

Silver Sulfadiazine Gauze Dressing Group (Silver Sulfadiazine Gauze Dressing Group) — University of the Philippines. Silver sulfadiazine has antimicrobial properties that help prevent infection in wounds.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Approval / PDUFA
Silver Sulfadiazine Gauze Dressing Group TARGET	Silver Sulfadiazine Gauze Dressing Group	University of the Philippines	phase 3	Antibacterial
Fetroja	CEFIDEROCOL	Shionogi	marketed	Cephalosporin Antibacterial	2019-01-01
Xenleta	LEFAMULIN	Hong Kong	marketed	Pleuromutilin Antibacterial	2019-01-01
Nuzyra	OMADACYCLINE TOSYLATE	Paratek Pharms	marketed	Tetracycline-class Antibacterial [EPC]	2018-01-01
Nuzyra	OMADACYCLINE	Paratek Pharms	marketed	Tetracycline-class Antibacterial [EPC]	2018-01-01
Baxdela	DELAFLOXACIN	Melinta	marketed	Fluoroquinolone Antibacterial	2017-01-01
Dalvance	DALBAVANCIN	AbbVie	marketed	Lipoglycopeptide Antibacterial	2014-01-01

Recent regulatory actions (last 90 days)

2026-02-26 — Dalvance · FDA · approved · US · AbbVie

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antibacterial class)

University of Baghdad · 1 drug in this class
University of Guarulhos · 1 drug in this class
University of the Philippines · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Silver Sulfadiazine Gauze Dressing Group — Competitive Intelligence Brief. https://druglandscape.com/ci/silver-sulfadiazine-gauze-dressing-group. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab